Smith+Nephew Held Back by Strategic Execution and Supply Chain

Smith+Nephew reported 2Q22 orthopedic sales of $891.6 million, -4.2% compared to 2Q21.

According to company leadership, challenges from the pandemic hid some pre-existing structural issues with Smith+Nephew's strategic execution and supply chain reliability.

Recently-appointed CEO Deepak Nath said, "We've become more complex and less...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us